FDA Continues to Expand Recall of Heart Drug Valsartan

In this undated photo, the FDA has expanded its recall of valsartan. NTD TV secreenshot

The U.S. Food and Drug Administration (FDA) expanded on its recall of medications that contain valsartan, a blood pressure and heart failure prevention drug.

The FDA’s list (pdf) was updated on Aug. 27.